6383. Delfeta-Sed Stedytabs and Delfeta-Sed plus T Stedytabs.    (F.D.C. No.
44676.    S. Nos. 3-801/2 R.)
QUANTITY: 2 drums, containing 42,000 tablets (Lot No. 996) and 61,000 tablets 
(Lot No. 997) respectively in bulk, 10,000 tablets in unlabeled cellophane bags, 
and 250   30-tablet pkgs. at Baltimore, Md.
SHIPPED : On 4-25-60 and 4-26-60, from St. Louis, Mo., by Victor M. Hermelin 
&Co.
LABEL IN PART: (Drum) "Lot No. 996 * * * Delfeta-Sed Stedytabs Each 
tablet contains: *Delfetamine 30 mg. #Sedafax 120 mg. (Warning: May be 
habit forming) * * * * Registered Trademark of dl-N-methyl-beta-phenyliso- 
propylamine Hydrochloride. #Trademark of special micronized grade of 
Amobarbital, USP;" (drum) "Lot No. 997 * * * Delfeta-Sed plus T Stedy- 
tabs Each tablet contains: * Delfetamine 30 mg. # Sedafax 120 mg. (Warn- 
ing: May be habit forming) ?Triroid 2*4 gr. * * * *Registered Trademark 
of dl-N-methyl-beta-phenylisopropylamine Hydrochloride. ^Trademark of 
special micronized grade of Amobarbital, USP ?Trademark of triple-assayed 
Thyroid, USP;" and (30-tablet pkgs.) "Stedytabs Sustained Release Tablets 
Delfeta-Sed plus T    Delfetamine with Sedafax & Triroid."
RESULTS OF INVESTIGATION: Investigation revealed that the 10,000 tablets in 
unlabeled cellophane bags were rejects of Lot No. 997; and that the 250 30- 
tablet packages contained tablets repacked by Eastern Research Laboratories, 
Inc., from Lot No. 997. The tablets of Lot No. 996 contained methamphetamine 
hydrochloride and amobarbital and those of Lot No. 997 contained metham- 
phetamine hydrochloride, thyroid, and amoharbitaL
LIBELED :    6-21-60, Dist. Md.
CHARGE: 502(d)-the articles contained a chemical derivative of barbituric 
acid, and their labels failed to bear the name of the drug and. in juxtaposition 
therewith, the statement "Warning: May be habit forming."; and 505(a) - 
the articles were new drugs which may not be introduced into interstate com- 
merce, since applications filed pursuant to law were not effective with respect . 
to such drugs.
DISPOSITION :   8-8-60.   Default-destruction.
VIOLATIVE SALES OF PRESCRIPTION DRUGS